Bénédicte Piron

2PUBLICATIONS
3CO-AUTHORS
Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 19, 2026
Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directions.

Bénédicte Piron, Philippe Moreau, Cyrille Touzeau

|Oct 14, 2023
Quad-class exposed/refractory myeloma is associated with short survival.

Bénédicte Piron, Domitille Costes-Tertrais, Thomas Gastinne

Pageof 1